120.40p-1.60 (-1.31%)03 May 2024, 16:37
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Syncona Limited Market & Company News

23.03.2022 08:30SYNCFreeline enters into ADS purchase agreementRNS
11.03.2022 08:44SYNCSyncona to invest further USD20 million in Freeline TherapeuticsAlliance
11.03.2022 07:00SYNCFreeline registered direct offeringRNS
10.03.2022 12:05SYNCAutolus Reports Full Year 2021 Financial ResultsRNS
09.03.2022 16:39SYNCDirector/PDMR ShareholdingRNS
09.03.2022 15:09SYNCHolding(s) in CompanyRNS
07.03.2022 17:29SYNCDirector/PDMR ShareholdingRNS
01.03.2022 12:56SYNCAchilles reports Full Year 2021 ResultsRNS
18.02.2022 10:03SYNCSyncona completes USD1.5 billion sale of Gyroscope to NovartisAlliance
18.02.2022 07:00SYNCCompletion of sale of Gyroscope TherapeuticsRNS
10.02.2022 07:00SYNC3rd Quarter ResultsRNS
08.02.2022 12:05SYNCFreeline presents data in Fabry diseaseRNS
31.12.2021 07:00SYNCDirectorate ChangeRNS
22.12.2021 07:00SYNCGyroscope to be acquired for up to $1.5 billionRNS
16.12.2021 07:00SYNCSyncona cornerstones Anaveon Series BRNS
14.12.2021 07:00SYNCFreeline reports 2022 priorities and guidanceRNS
13.12.2021 14:05SYNCFreeline presents data in haemophilia BRNS
13.12.2021 12:05SYNCAutolus presents positive AUTO1 (obe-cel) dataRNS
29.11.2021 07:00SYNCSyncona co-leads Series B financing in QuellRNS
22.11.2021 07:00SYNCSyncona appoints new DirectorsRNS
12.11.2021 13:56SYNCAchilles Presents Data at the SITC Annual MeetingRNS
11.11.2021 07:00SYNCHalf-year ReportRNS
10.11.2021 07:00SYNCFreeline reports new data and 3rd Quarter ResultsRNS
09.11.2021 13:31SYNCAchilles reports Third Quarter Financial ResultsRNS
08.11.2021 13:05SYNCGyroscope Announces Sanofi Equity InvestmentRNS
08.11.2021 07:00SYNCBlackstone Life Science to invest $250m in AutolusRNS
03.11.2021 11:07SYNCSyncona leads $87 million financing of CladeRNS
03.11.2021 11:05SYNCAutolus reports Q3 2021 Financial ResultsRNS
26.10.2021 07:00SYNCNotice of ResultsRNS
30.09.2021 15:59SYNCGyroscope announces additional positive dataRNS
17.08.2021 07:00SYNCFirst Quarter UpdateRNS
16.08.2021 12:07SYNCFreeline Reports Executive Change and Q2 ResultsRNS
10.08.2021 12:05SYNCAchilles reports Second Quarter 2021 ResultsRNS
05.08.2021 12:05SYNCAutolus reports Q2 2021 Financial ResultsRNS
03.08.2021 13:16SYNCResult of AGM - ReplacementRNS
03.08.2021 12:32SYNCResult of AGMRNS
30.07.2021 12:17SYNCTotal Voting RightsRNS
27.07.2021 14:41SYNCHolding(s) in CompanyRNS
15.07.2021 12:57SYNCIssue of shares pursuant to incentive schemeRNS
01.07.2021 11:54SYNCPublication of 2021 Annual Report & Notice of AGMRNS
24.06.2021 07:00SYNCAnaveon doses first patient in Phase I/II studyRNS
17.06.2021 07:00SYNCFinal ResultsRNS
17.06.2021 07:00SYNCSyncona announces expansion of leadership teamRNS
11.06.2021 12:05SYNCAutolus to present additional data in AUTO1RNS
18.05.2021 07:00SYNCNotice of ResultsRNS
18.05.2021 07:00SYNCFreeline reports Q1 resultsRNS
12.05.2021 15:05SYNCAutolus to present additional data in AUTO1RNS
12.05.2021 13:18SYNCDirector/PDMR ShareholdingRNS
11.05.2021 12:05SYNCAchilles reports Q1 financial resultsRNS
07.05.2021 07:00SYNCGyroscope Therapeutics update on proposed IPORNS
06.05.2021 12:05SYNCAutolus reports Q1 2021 Financial ResultsRNS
04.05.2021 07:00SYNCUpdate on Gyroscope proposed IPO in the USRNS
19.04.2021 12:05SYNCAutolus appoints non-executive ChairRNS
19.04.2021 07:00SYNCGyroscope files registration statementRNS
06.04.2021 16:00SYNCDirector/PDMR ShareholdingRNS
01.04.2021 07:00SYNCFreeline Reports Financial ResultsRNS
31.03.2021 07:00SYNCAchilles update on IPORNS
30.03.2021 12:04SYNCDirector/PDMR ShareholdingRNS
26.03.2021 07:06SYNCGyroscope announces additional financing plansRNS
26.03.2021 07:00SYNCSyncona cornerstones $148m Series C in GyroscopeRNS
25.03.2021 11:13SYNCUpdate on Achilles’ proposed IPORNS
04.03.2021 12:10SYNCAutolus Reports Full Year 2020 Financial ResultsRNS
02.03.2021 07:00SYNCAchilles files registration statementRNS
12.02.2021 15:49SYNCGyroscope Announces Positive Interim DataRNS
11.02.2021 07:00SYNCNew commitment to Quell in largest ever Series ARNS
11.02.2021 07:00SYNCQuarterly and Business UpdateRNS
10.02.2021 07:00SYNCAutolus announces pricing of public offeringRNS
08.02.2021 12:09SYNCFreeline Updates Clinical Development PlanRNS
05.02.2021 07:00SYNCAchilles announces additional financing plansRNS
05.02.2021 07:00SYNCAchilles data and safety committee reviewRNS
06.01.2021 07:00SYNCAutolus Business OutlookRNS
Showing 301 to 371 of 371